The Mondre and Lane families’ philanthropic support will fund study utilizing a current FDA-approved drug to benefit large number of children with Eosinophilic Esophagitis (EoE).

CHOP was recently awarded $869,672 by the FCC as part of the agency’s COVID-19 Telehealth Program. The grant will be used to fund three critical streams of work at CHOP.

Results from multicenter study are first to show improved production of coagulation factor VIII over prolonged period, leading to reduction or complete elimination of bleeding events.

Rates of depression and suicide have been rising in children, teens, and young adults fr two decades. Before the COVID-19 pandemic hit the United States, 1 in 5 children under age 18 experienced a mental health condition. The "Sound the Alarm" campaign aims to break down barriers to mental health access.

The National Organization for Rare Disorders announced 31 centers to achieve better outcomes for all members of the rare disease community.

CHOP provided COVID-19 vaccination to underserved Philadelphia neighborhoods and vulnerable populations through multiple community partnerships.

Guiding children through the grieving process allows them to learn healthy ways to deal with their emotions when a loved one dies.

Using a model developed at CHOP, researchers find high cost of treatment most likely to prevent premature death in patients with agammaglobulinemia undermines its benefits.

Supported by a second philanthropic gift from Reed Smith, CHOP will be able to offer pro bono legal services to select families receiving care at its South Philadelphia Primary Care Center.

CHOP has earned the 2022 Military Friendly® Employer designation for its role in fostering a meaningful work environment for veterans, service members, and their families.